4.7 Article

A novel subset of helper T cells promotes immune responses by secreting GM-CSF

Journal

CELL DEATH AND DIFFERENTIATION
Volume 20, Issue 12, Pages 1731-1741

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/cdd.2013.130

Keywords

helper T cell; GM-CSF; apoptosis; cytokine

Funding

  1. USPHS [AI43384, AI057596, DE014913, DE019932, GM866889]
  2. Ministry of Science and Technology of China [2010CB945600]
  3. National Science and Technology Project of China [2009ZX09503-024]

Ask authors/readers for more resources

Helper T cells are crucial for maintaining proper immune responses. Yet, they have an undefined relationship with one of the most potent immune stimulatory cytokines, granulocyte macrophage-colony-stimulating factor (GM-CSF). By depleting major cytokines during the differentiation of CD4(+) T cells in vitro, we derived cells that were found to produce large amounts of GM-CSF, but little of the cytokines produced by other helper T subsets. By their secretion of GM-CSF, this novel subset of helper T cells (which we have termed ThGM cells) promoted the production of cytokines by other T-cell subtypes, including type 1 helper T cell (Th1), type 2 helper T cell (Th2), type 1 cytotoxic T cell (Tc1), type 2 cytotoxic T cell (Tc2), and naive T cells, as evidenced by the fact that antibody neutralization of GM-CSF abolished this effect. ThGM cells were found to be highly prone to activation-induced cell death (AICD). Inhibitors of TRAIL or granzymes could not block AICD in ThGM cells, whereas inhibition of FasL/Fas interaction partially rescued ThGM cells from AICD. Thus, ThGM cells are a novel subpopulation of T helper cells that produce abundant GM-CSF, exhibit exquisite susceptibility to apoptosis, and therefore play a pivotal role in the regulation of the early stages of immune responses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Multidisciplinary

SCD1 Sustains Homeostasis of Bulge Niche via Maintaining Hemidesmosomes in Basal Keratinocytes

Yueqing Xue, Liangyu Lin, Qing Li, Keli Liu, Mingyuan Hu, Jiayin Ye, Jianchang Cao, Jingjie Zhai, Fanjun Zheng, Yu Wang, Tao Zhang, Liming Du, Cheng Gao, Guan Wang, Xuefeng Wang, Jun Qin, Xinhua Liao, Xiangyin Kong, Lydia Sorokin, Yufang Shi, Ying Wang

Summary: The role of fatty acid desaturation catabolized by SCD1 in regulating hair follicle stem cells and hair growth has been discovered. The absence of SCD1 leads to abnormal hair growth, affecting the appearance and quality of hair.

ADVANCED SCIENCE (2023)

Article Chemistry, Multidisciplinary

Disturbance of suprachiasmatic nucleus function improves cardiac repair after myocardial infarction by IGF2-mediated macrophage transition

Kai-li Hao, Qiao-cheng Zhai, Yue Gu, Yue-qiu Chen, Ya-ning Wang, Rui Liu, Shi-ping Yan, Ying Wang, Yu-fang Shi, Wei Lei, Zhen-ya Shen, Ying Xu, Shi-jun Hu

Summary: In this study, researchers disrupted the function of the suprachiasmatic nucleus (SCN) in mice and found that it played a significant role in promoting cardiac repair after myocardial infarction (MI). The study showed that SCN disruption led to the promotion of angiogenesis, reduction of cardiac fibrosis, and altered gene expression in the heart related to inflammatory response and cytokine-cytokine receptor interaction. Additionally, exposure to a desynchronizing condition (constant light) had similar protective effects, suggesting that the effect was mediated by the SCN itself and not by the self-sustained molecular clock.

ACTA PHARMACOLOGICA SINICA (2023)

Review Biochemistry & Molecular Biology

Apoptotic cell death in disease-Current understanding of the NCCD 2023

Ilio Vitale, Federico Pietrocola, Emma Guilbaud, Stuart A. Aaronson, John M. Abrams, Dieter Adam, Massimiliano Agostini, Patrizia Agostinis, Emad S. Alnemri, Lucia Altucci, Ivano Amelio, David W. Andrews, Rami Aqeilan, Eli Arama, Eric H. Baehrecke, Siddharth Balachandran, Daniele Bano, Nickolai A. Barlev, Jiri Bartek, Nicolas G. Bazan, Christoph Becker, Francesca Bernassola, Mathieu J. M. Bertrand, Marco E. Bianchi, Mikhail V. Blagosklonny, J. Magarian Blander, Giovanni Blandino, Klas Blomgren, Christoph Borner, Carl D. Bortner, Pierluigi Bove, Patricia Boya, Catherine Brenner, Petr Broz, Thomas Brunner, Rune Busk Damgaard, George A. Calin, Michelangelo Campanella, Eleonora Candi, Michele Carbone, Didac Carmona-Gutierrez, Francesco Cecconi, Francis K-M Chan, Guo-Qiang Chen, Quan Chen, Youhai H. Chen, Emily H. Cheng, Jerry E. Chipuk, John A. Cidlowski, Aaron Ciechanover, Gennaro Ciliberto, Marcus Conrad, Juan R. Cubillos-Ruiz, Peter E. Czabotar, Vincenzo D'Angiolella, Mads Daugaard, Ted M. Dawson, Valina L. Dawson, Ruggero De Maria, Bart De Strooper, Klaus-Michael Debatin, Ralph J. Deberardinis, Alexei Degterev, Giannino Del Sal, Mohanish Deshmukh, Francesco Di Virgilio, Marc Diederich, Scott J. Dixon, Brian D. Dynlacht, Wafik S. El-Deiry, John W. Elrod, Kurt Engeland, Gian Maria Fimia, Claudia Galassi, Carlo Ganini, Ana J. Garcia-Saez, Abhishek D. Garg, Carmen Garrido, Evripidis Gavathiotis, Motti Gerlic, Sourav Ghosh, Douglas R. Green, Lloyd A. Greene, Hinrich Gronemeyer, Georg Haecker, Gyorgy Hajnoczky, J. Marie Hardwick, Ygal Haupt, Sudan He, David M. Heery, Michael O. Hengartner, Claudio Hetz, David A. Hildeman, Hidenori Ichijo, Satoshi Inoue, Marja Jaeaettelae, Ana Janic, Bertrand Joseph, Philipp J. Jost, Thirumala-Devi Kanneganti, Michael Karin, Hamid Kashkar, Thomas Kaufmann, Gemma L. Kelly, Oliver Kepp, Adi Kimchi, Richard N. Kitsis, Daniel J. Klionsky, Ruth Kluck, Dmitri Krysko, Dagmar Kulms, Sharad Kumar, Sergio Lavandero, Inna N. Lavrik, John J. Lemasters, Gianmaria Liccardi, Andreas Linkermann, Stuart A. Lipton, Richard A. Lockshin, Carlos Lopez-Otin, Tom Luedde, Marion MacFarlane, Frank Madeo, Walter Malorni, Gwenola Manic, Roberto Mantovani, Saverio Marchi, Jean-Christophe Marine, Seamus J. Martin, Jean-Claude Martinou, Pier G. Mastroberardino, Jan Paul Medema, Patrick Mehlen, Pascal Meier, Gerry Melino, Sonia Melino, Edward A. Miao, Ute M. Moll, Cristina Munoz-Pinedo, Daniel J. Murphy, Maria Victoria Niklison-Chirou, Flavia Novelli, Gabriel Nunez, Andrew Oberst, Dimitry Ofengeim, Joseph T. Opferman, Moshe Oren, Michele Pagano, Theocharis Panaretakis, Manolis Pasparakis, Josef M. Penninger, Francesca Pentimalli, David M. Pereira, Shazib Pervaiz, Marcus E. Peter, Paolo Pinton, Giovanni Porta, Jochen H. M. Prehn, Hamsa Puthalakath, Gabriel A. Rabinovich, Krishnaraj Rajalingam, Kodi S. Ravichandran, Markus Rehm, Jean-Ehrland Ricci, Rosario Rizzuto, Nirmal Robinson, Cecilia M. P. Rodrigues, Barak Rotblat, Carla Rothlin, David C. Rubinsztein, Thomas Rudel, Alessandro Rufini, Kevin M. Ryan, Kristopher A. Sarosiek, Akira Sawa, Emre Sayan, Kate Schroder, Luca Scorrano, Federico Sesti, Feng Shao, Yufang Shi, Giuseppe S. Sica, John Silke, Hans-Uwe Simon, Antonella Sistigu, Anastasis Stephanou, Brent R. Stockwell, Flavie Strapazzon, Andreas Strasser, Liming Sun, Erwei Sun, Qiang Sun, Gyorgy Szabadkai, Stephen W. G. Tait, Daolin Tang, Nektarios Tavernarakis, Carol M. Troy, Boris Turk, Nicoletta Urbano, Peter Vandenabeele, Tom Vanden Berghe, Matthew G. Vander Heiden, Jacqueline L. Vanderluit, Alexei Verkhratsky, Andreas Villunger, Silvia von Karstedt, Anne K. Voss, Karen H. Vousden, Domagoj Vucic, Daniela Vuri, Erwin F. Wagner, Henning Walczak, David Wallach, Ruoning Wang, Ying Wang, Achim Weber, Will Wood, Takahiro Yamazaki, Huang-Tian Yang, Zahra Zakeri, Joanna E. Zawacka-Pankau, Lin Zhang, Haibing Zhang, Boris Zhivotovsky, Wenzhao Zhou, Mauro Piacentini, Guido Kroemer, Lorenzo Galluzzi

Summary: Apoptosis is a regulated cell death process involving caspase family proteases. Inhibiting or delaying apoptosis experimentally through pharmacological and genetic strategies has demonstrated its importance in embryonic development, tissue homeostasis, and the pathogenesis of various human disorders. Defects in apoptotic cell death machinery impair development and promote oncogenesis, while inappropriate activation of apoptosis contributes to cell loss and tissue damage in neurological, cardiovascular, renal, hepatic, infectious, neoplastic, and inflammatory conditions.

CELL DEATH AND DIFFERENTIATION (2023)

Article Cell & Tissue Engineering

An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells (MSC) Committee perspectives on International Standards Organization/Technical Committee 276 Biobanking Standards for bone marrow-MSCs and umbilical cord tissue-derived MSCs for research purposes

Sowmya Viswanathan, Katarina Le Blanc, Rachele Ciccocioppo, Georges Dagher, Anthony J. Filiano, Jacques Galipeau, Mauro Krampera, Lena Krieger, Manoj M. Lalu, Jan Nolta, Viviana Marcela Rodriguez Pardo, Yufang Shi, Karin Tarte, Daniel J. Weiss, Ivan Martin

Summary: The International Standards Organization (ISO) has recently published ISO standardization documents for MSC(WJ) and MSC(M) biobanking, which standardize the terminology and functional characterization of MSCs. These documents, developed with input from ISCT, provide requirements and recommendations for functional characterization of MSC(WJ) and MSC(M) and represent an international consensus on MSC identity and characterization. They are an important first step in standardizing MSC biobanking and characterization for research and development.

CYTOTHERAPY (2023)

Article Immunology

Cotreatment With Clofazimine and Rapamycin Eliminates Drug-Resistant Tuberculosis by Inducing Polyfunctional Central Memory T-Cell Responses

Dhiraj Kumar Singh, Ashima Bhaskar, Isha Pahuja, Aishwarya Shaji, Barnani Moitra, Yufang Shi, Ved Prakash Dwivedi, Gobardhan Das

Summary: Tuberculosis caused by Mycobacterium tuberculosis is becoming increasingly drug resistant, highlighting the urgent need for alternative therapies. Combined treatment with antibiotics and an immunomodulator, such as clofazimine and rapamycin, shows promise in eliminating both multiple drug-resistant and extensively drug-resistant strains of M. tuberculosis. This treatment induces robust T-cell memory and polyfunctional T-CM responses, reducing the expression of latency-associated genes and providing a potential solution for treating drug-resistant tuberculosis.

JOURNAL OF INFECTIOUS DISEASES (2023)

Article Multidisciplinary Sciences

ZFP750 affects the cutaneous barrier through regulating lipid metabolism

Alessio Butera, Massimiliano Agostini, Matteo Cassandri, Francesca De Nicola, Maurizio Fanciulli, Lorenzo D'Ambrosio, Laura Falasca, Roberta Nardacci, Lu Wang, Mauro Piacentini, Richard A. Knight, Wei Jia, Qiang Sun, Yufang Shi, Ying Wang, Eleonora Candi, Gerry Melino

Summary: An essential function of the epidermis is to provide a physical barrier that prevents water loss. Alteration of ceramides, cholesterol, and very long chain fatty acids, mediators of this barrier function, causes human pathologies. A study shows that genetic deletion of ZFP750 in mice leads to the loss of epidermal barrier function due to a reduction in ceramides. ZFP750 directly and/or indirectly regulates the expression of enzymes involved in ceramide biosynthesis, contributing to our understanding of skin disease pathogenesis.

SCIENCE ADVANCES (2023)

Review Biology

Aged mesenchymal stem cells and inflammation: from pathology to potential therapeutic strategies

Xue Yang, Ying Wang, Valentina Rovella, Eleonora Candi, Wei Jia, Francesca Bernassola, Pierluigi Bove, Mauro Piacentini, Manuel Scimeca, Giuseppe Sica, Giuseppe Tisone, Alessandro Mauriello, Lixin Wei, Gerry Melino, Yufang Shi

Summary: Natural ageing of organisms and age-related diseases are mainly caused by stem cell ageing and inflammaging. Mesenchymal stem cells (MSCs) have high immune-regulating capacity and are potential candidates for immune-related disease treatment. However, MSC application is not satisfactory for some patients, especially the elderly, possibly due to changes in MSCs with ageing, including reduced cell population and differentiation ability, decreased migratory and homing capacity, and defective immunosuppression. It is important to explore the relationship between inflammaging and aged MSCs in order to prevent age-related diseases and improve the therapeutic effects of MSCs. This review discusses the changes in naturally ageing MSCs mainly from an inflammation perspective and proposes ideas for rejuvenating aged MSCs in future treatments.

BIOLOGY DIRECT (2023)

Review Biochemistry & Molecular Biology

Deer antlers: the fastest growing tissue with least cancer occurrence

Chunyi Li, Yan Li, Wenying Wang, Manuel Scimeca, Gerry Melino, Rui Du, Yufang Shi

Summary: Deer antlers possess unique attributes acquired during evolution, such as fast growth, anti-cancer properties, and efficient apoptosis mechanism. The inner layer of deer antlers' reserve mesenchyme cells is more adapted to osteosarcoma, but acquires energy through aerobic oxidative phosphorylation. Deer have highly positively selected cancer suppressive genes. Experimental results using antler extracts and reserve mesenchyme cells/exosomes on cancer models have shown positive outcomes, supporting the potential clinical applications of deer antlers.

CELL DEATH AND DIFFERENTIATION (2023)

Article Cell Biology

PML-mediated nuclear loosening permits immunomodulation of mesenchymal stem/stromal cells under inflammatory conditions

Yunpeng Chu, Zishan Jiang, Zheng Gong, Xiaocao Ji, Mengting Zhu, Qianwen Shang, Pixia Gong, Lijuan Cao, Yongjing Chen, Peishan Li, Changshun Shao, Yufang Shi

Summary: This study reveals that human mesenchymal stromal cells (hMSCs) undergo nuclear reconfiguration under the stimulation of inflammatory cytokines, which is associated with their immunomodulatory function. The results indicate that the immunomodulatory function of hMSCs conferred by inflammatory cytokines requires PML-mediated chromatin loosening.

CELL PROLIFERATION (2023)

Review Biochemistry & Molecular Biology

Alleviating hypoxia to improve cancer immunotherapy

Peng Fan, Naidong Zhang, Eleonora Candi, Massimiliano Agostini, Mauro Piacentini, Yuhui TOR Ctr, Yufang Shi, Yuhui Huang, Gerry Melino

Summary: Tumor hypoxia is a significant barrier to immunotherapy. Vascular normalization strategy can restore tumor blood vessel structure and function, alleviate hypoxia, and enhance cancer immunotherapy efficacy.

ONCOGENE (2023)

Article Biochemistry & Molecular Biology

Mesenchymal stromal cells confer breast cancer doxorubicin resistance by producing hyaluronan

Zhanhong Liu, Pengbo Hou, Jiankai Fang, Jingyu Zhu, Juanmin Zha, Rui Liu, Yayun Ding, Muqiu Zuo, Peishan Li, Lijuan Cao, Chao Feng, Gerry Melino, Changshun Shao, Yufang Shi

Summary: Chemotherapy resistance in breast cancer can be induced by mesenchymal stromal cells (MSCs) through reducing the intratumoral accumulation of doxorubicin. This resistance is mediated by hyaluronan (HA), a major extracellular matrix (ECM) product of MSCs, which can bind with doxorubicin and inhibit its entry into breast cancer cells. High levels of HA in the serum are positively associated with chemoresistance in breast cancer patients.

ONCOGENE (2023)

Article Cell Biology

A BRCA2 germline mutation and high expression of immune checkpoints in a TNBC patient

Yuyi Han, Valentina Rovella, Artem Smirnov, Oreste Claudio Buonomo, Alessandro Mauriello, Tommaso Perretta, Yufang Shi, Jonathan Woodmsith, Julia Bischof, Pierluigi Bove, Hartmut Juhl, Manuel Scimeca, Giuseppe Sica, Giuseppe Tisone, Ying Wang, Erica Giacobbi, Marco Materazzo, Gerry Melino, Eleonora Candi, Francesca Bernassola

Summary: This case report highlights the link between BRCA2 inactivation and increased expression of immune checkpoints in TNBC patients, emphasizing the importance of genetic and biomarker screening for potential efficacy of immunotherapies.

CELL DEATH DISCOVERY (2023)

Article Cell Biology

IL4I1-catalyzed tryptophan metabolites mediate the anti-inflammatory function of cytokine-primed human muscle stem cells

Muqiu Zuo, Jiankai Fang, Peiqing Huang, Shisong Liu, Pengbo Hou, Shiqing Wang, Zhanhong Liu, Chao Feng, Lijuan Cao, Peishan Li, Yufang Shi, Changshun Shao

Summary: Muscle stem cells (MuSCs) exhibit therapeutic efficacy by regulating inflammatory microenvironments, but the mechanism underlying their immunoregulatory property is not well characterized. This study demonstrated that IL4I1, an essential enzyme in indole metabolism, was highly expressed in human MuSCs treated with IFN-γ and TNF-α. MuSCs inhibited neutrophil infiltration and ameliorated acute lung injury in mice through an IL4I1-dependent manner. Mechanistically, IL4I1-produced indole metabolites acted as ligands to activate aryl hydrocarbon receptor (AHR), increasing the expression of TNF-stimulated gene 6 (TSG-6) in inflammatory cytokine-primed MuSCs. Additionally, administration of indole-3-pyruvic acid (I3P) alone suppressed neutrophil infiltration and reduced reactive oxygen species levels in neutrophils. This study reveals a novel mechanism by which MuSCs acquire their immunoregulatory property and provides insights for developing MuSC-based therapies for inflammatory diseases.

CELL DEATH DISCOVERY (2023)

Article Cell Biology

A primary luminal/HER2 negative breast cancer patient with mismatch repair deficiency

Xue Yang, Artem Smirnov, Oreste Claudio Buonomo, Alessandro Mauriello, Yufang Shi, Julia Bischof, Jonathan Woodsmith, Francesca TOR CENTRE, Gerry Melino, Eleonora Candi, Francesca Bernassola

Summary: In this study, a comprehensive analysis of a 47-year-old woman with luminal B breast cancer was conducted, including gene mutations, chromosomal alterations, mRNA and protein expression changes. The findings revealed a potentially hyper-activating point mutation in the FGFR2 gene, along with over-expression of its ligand FGF20 due to genomic amplification. The patient also had somatic and germline mutations in mismatch repair (MMR) genes, suggesting a defective MMR system. High levels of microsatellite instability (MSI) and tumor mutational burden (TMB), along with increased expression of CTLA-4 and PD-1, implicated abnormal FGFR signaling and defective MMR system in the development of this breast tumor. The study highlights the importance of accurate molecular characterization for individualized treatment and targeted therapy, especially for breast cancer subtypes with adverse outcome.

CELL DEATH DISCOVERY (2023)

Article Endocrinology & Metabolism

Glycolytic neutrophils accrued in the spleen compromise anti-tumour T cell immunity in breast cancer

Yu Wang, Muhan Xu, Jian Sun, Xiaoxiao Li, Huazheng Shi, Xuefeng Wang, Benming Liu, Tao Zhang, Xu Jiang, Liangyu Lin, Qing Li, Yin Huang, Yong Liang, Mingyuan Hu, Fanjun Zheng, Fengyu Zhang, Jian Sun, Yufang Shi, Ying Wang

Summary: In this study, the researchers investigate how interactions between neutrophils and T cells in lymphoid tissues away from the tumour area, as well as metabolic competition between these immune cell populations, impair anti-tumour immunity in breast cancer. They found that the spleens of both humans and mice with breast cancer undergo metabolic reprogramming to a glycolytic state, which influences the microenvironment and negatively affects T cell responses. They also discovered that the CCL9 chemokine produced by splenic stromal cells is crucial for neutrophil accumulation, and blocking the CCR1 receptor promotes tumour eradication.

NATURE METABOLISM (2023)

No Data Available